Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05418972
Title A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma (Neo ReNi II)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Melanoma Institute Australia
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Melanoma Institute Australia RECRUITING Wollstonecraft New South Wales 2065 Australia Details
*Shaded cells indicate that there was no data available from for the field